PMID: 75391Feb 18, 1978Paper

Trial of prostaglandin-synthetase inhibitors in primary dysmenorrhoea

Lancet
A B AndersonA C Turnbull

Abstract

The prostaglandin-synthetase inhibitors, mefenamic acid and flufenamic acid, were compared with the analgesic, dextropropoxyphene/paracetamol, in the treatment of primary dysmenorrhoea in a double-blind crossover trial. Results were assessed in 30 patients who took each drug during menstruation for three consecutive cycles. The patients' assessment of each drug suggests that both mefenamic acid and flufenamic acid are more effective than the other analgesic for general relief of symptoms and for most of nine individual symptoms subjectively assessed by the patient. There was less absenteeism from work or school during mefenamic-acid treatment and fewer capsules of mefenamic acid were taken compared with the other two drugs. Patients took significantly fewer additional analgesics during mefenamic-acid therapy than during treatment with the other two drugs. 5 patients had possible side-effects--3 patients on mefenamic acid and 2 on dextropropoxyphene/paracetamol.

Citations

Dec 18, 1978·European Journal of Clinical Pharmacology·T JanbuB I Nesheim
May 1, 1988·The Journal of International Medical Research·S Or, A Bozkurt
Jan 1, 1980·Current Medical Research and Opinion·D P EvansR G Newcombe
Oct 1, 1980·British Journal of Clinical Pharmacology·A E Farah, F Rosenberg
May 10, 2013·Expert Review of Clinical Pharmacology·Nevio Cimolai
Aug 1, 1979·Archives of Gynecology·B SandahlK E Andersson
Jul 1, 1984·British Journal of Obstetrics and Gynaecology·M C ReesA C Turnbull
Jun 1, 1983·Irish Journal of Medical Science·R F Harrison
Jan 1, 1978·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·H A SandeA Izu
Nov 1, 1979·The Australian & New Zealand Journal of Obstetrics & Gynaecology·C WoodR Williams
Jun 1, 1989·British Journal of Obstetrics and Gynaecology·L L Wall, D W Warrell
Apr 1, 1980·British Journal of Obstetrics and Gynaecology·J R Pogmore, G M Filshie
Jun 1, 1980·British Journal of Clinical Pharmacology·U R KrishnaU K Sheth
Aug 1, 2015·The Cochrane Database of Systematic Reviews·Jane MarjoribanksMichelle Proctor
Mar 15, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Athanasios Mantas, Albert Mihranyan
Aug 1, 1979·British Journal of Obstetrics and Gynaecology·M G Elder, L Kapadia
Jan 1, 1984·Drug Intelligence & Clinical Pharmacy·N J Wenzloff, L Shimp
Aug 6, 1998·British Journal of Obstetrics and Gynaecology·W Y Zhang, A Li Wan Po
Nov 1, 1979·British Journal of Clinical Pharmacology·G J Sanger, A Bennett
Feb 1, 1981·Prostaglandins and Medicine·O YlikorkalaA Kauppila

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.